One of two newly designated NCI Cancer Centers (2007), the Stanford Cancer Center
is committed to applying advances in basic research to the improvement of cancer
prevention and clinical care. The translational research programs are based upon
institutional strengths in basic science and technology development. The Center is
run in partnership with Stanford Hospitals & Clinics the Lucile Packard Children's
Hospital, and the Palo Alto Veteran's Hospital. Ten multidisciplinary research
programs include areas of particular strength in molecular imaging, immunology and
immunotherapy, bone marrow transplantation, cancer stem cells, and radiobiology.
Partnership with the Northern California Cancer Center enhances the Center's
epidemiology, prevention and outreach programs.
With over 270 members, NCI funding of over $38 million, and a newly opened clinical
cancer center, the Center brings together faculty with cancer-relevant expertise
from 4 Schools and 30 Departments throughout Stanford University. Planning has begun
for a 200,000 sq. ft. laboratory-based research facility that will house newly
recruited faculty in cancer and stem cell research. The Center participates in NCI-funded
programs in nanotechnology, the tumor microenvironment and computational biology.
Stanford has recently been named a Ludwig Center based on its expertise in cancer
stem cell research. Dr. Irving Weissman is Director of the Stanford Cancer Center
and the Ludwig Center for Cancer Stem Cell Research and Medicine.
 |
